PURPOSE: To investigate the Myocilin (MYOC) gene for mutations and polymorphisms in patients with primary open-angle glaucoma (POAG) in Morocco. METHODS: Fifty-seven patients with severe POAG, who suffered from complete or almost complete visual field loss, were included in the study. The MYOC coding region, including exon I, exon II, and the coding part of exon III, were screened for sequence alteration using denaturing high-performance liquid chromatography (DHPLC). Variant amplicons were sequenced bidirectionally. The control group consisted of 60 subjects from the general population. RESULTS: One disease-causing mutation, T377M, was observed in one POAG patient. In addition, 10 polymorphisms, namely P13P, R76K, R82H, G122G, T135I, L159L (often associated with P13P), T285T, T325T, Y347Y, and E396E, were detected in patients or in controls. The Q368X mutation that has been documented in Caucasian POAG patients was absent. CONCLUSIONS: MYOC is an infrequent genetic cause of severe POAG in Morocco. The absence of the POAG-associated Q368X mutation and the presence of particular polymorphisms, including P13P + L159L and T325T, could be specific features of the MYOC sequence in African populations.
PURPOSE: To investigate the Myocilin (MYOC) gene for mutations and polymorphisms in patients with primary open-angle glaucoma (POAG) in Morocco. METHODS: Fifty-seven patients with severe POAG, who suffered from complete or almost complete visual field loss, were included in the study. The MYOC coding region, including exon I, exon II, and the coding part of exon III, were screened for sequence alteration using denaturing high-performance liquid chromatography (DHPLC). Variant amplicons were sequenced bidirectionally. The control group consisted of 60 subjects from the general population. RESULTS: One disease-causing mutation, T377M, was observed in one POAG patient. In addition, 10 polymorphisms, namely P13P, R76K, R82H, G122G, T135I, L159L (often associated with P13P), T285T, T325T, Y347Y, and E396E, were detected in patients or in controls. The Q368X mutation that has been documented in Caucasian POAG patients was absent. CONCLUSIONS:MYOC is an infrequent genetic cause of severe POAG in Morocco. The absence of the POAG-associated Q368X mutation and the presence of particular polymorphisms, including P13P + L159L and T325T, could be specific features of the MYOC sequence in African populations.
Authors: George Kitsos; Zacharias Petrou; Maria Grigoriadou; John R Samples; Alex W Hewitt; Haris Kokotas; Aglaia Giannoulia-Karantana; David A Mackey; Mary K Wirtz; Marilita Moschou; John P A Ioannidis; Michael B Petersen Journal: Clin Ophthalmol Date: 2010-03-24
Authors: Kristin K McDonald; Karen Abramson; Marco A Beltran; Maria G Ramirez; Miguel Alvarez; Alice Ventura; Cecilia Santiago-Turla; Silke Schmidt; Michael A Hauser; R Rand Allingham Journal: J Hum Genet Date: 2010-07-29 Impact factor: 3.172
Authors: Alex W Hewitt; John R Samples; R Rand Allingham; Irma Järvelä; George Kitsos; Subbaiah R Krishnadas; Julia E Richards; Paul R Lichter; Michael B Petersen; Periasamy Sundaresan; Janey L Wiggs; David A Mackey; Mary K Wirtz Journal: Mol Vis Date: 2007-03-28 Impact factor: 2.367
Authors: Wenjing Liu; Yutao Liu; Pratap Challa; Leon W Herndon; Janey L Wiggs; Christopher A Girkin; R Rand Allingham; Michael A Hauser Journal: Mol Vis Date: 2012-08-10 Impact factor: 2.367